Navigation Links
Potential dangers faced by narcoleptics who use nicotine outlined in new abstract

WESTCHESTER, Ill. A research abstract that will be presented on Monday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS), provides the first description of nicotine use by narcolepsy patients. Because people with narcolepsy can fall asleep suddenly and without warning, even while eating, walking or driving, those who smoke nicotine in bed are at a high risk of burning either themselves or the objects around them, or starting a fire, if they fall asleep. Further, the excessive sleepiness brought on by their narcolepsy may also complicate any attempt by them to quit the habit of nicotine use.

The study, authored by Lois Krahn, MD, of the Mayo Clinic in Scottsdale, Ariz., focused on unpublished data from a community-based study of narcolepsy, followed by a questionnaire distributed at last years Narcolepsy Network national meeting to obtain more information.

According to the results, in the community-based study, 62.5 percent of narcolepsy patients were past or present smokers. Seventeen questionnaires were completed, in which 47 percent of respondents were past or present nicotine users. All respondents identified nicotine as an effective in decreasing sleepiness. Thirty-seven percent fell asleep while smoking. Twenty-five percent smoked in bed. Burns were reported by 75 percent involving clothing, furniture or carpet. One respondent started a fire. One substituted nicotine patches for cigarettes years ago to continue a powerful means to decrease cataplexy. All tried to quit smoking, but described having difficulty because sleepiness worsened without nicotine.

Burns are a potentially serious complication for patients smoking nicotine. Although burns appear to be common in our preliminary survey, the lack of a denominator precludes conclusions about their frequency. Narcolepsy patients who smoke may have more trouble quitting because of increased sleepiness. The role of nicotine to self-medicate sleepiness and cataplexy merits more study, said Dr. Krahn.

Narcolepsy is a sleep disorder that causes people to fall asleep uncontrollably during the day. It also includes features of dreaming that occur while awake. Other common symptoms include sleep paralysis, hallucinations and cataplexy. About one out of every 2,000 people is known to have narcolepsy. The chance that you have narcolepsy is higher when a relative also has it. Narcolepsy affects the same number of men and women.

It is recommended that adults get between seven and eight hours of nightly sleep.

The American Academy of Sleep Medicine (AASM) offers the following tips on how to get a good nights sleep:

  • Follow a consistent bedtime routine.

  • Establish a relaxing setting at bedtime.

  • Get a full nights sleep every night.

  • Avoid foods or drinks that contain caffeine, as well as any medicine that has a stimulant, prior to bedtime.

  • Do not bring your worries to bed with you.

  • Do not go to bed hungry, but dont eat a big meal before bedtime either.

  • Avoid any rigorous exercise within six hours of your bedtime.

  • Make your bedroom quiet, dark and a little bit cool.

  • Get up at the same time every morning.

Those who suspect that they might be suffering from narcolepsy, or another sleep disorder, are encouraged to consult with their primary care physician or a sleep specialist.


Contact: Kathleen McCann
American Academy of Sleep Medicine

Related medicine news :

1. Sun Pharma Comments on Taros Potential Sale of Its Irish Operations
2. Gene that magnetically labels cells shows potential as imaging tool
3. Potential treatments from cryptic genes
4. Most caregivers of young children lack basic knowledge of potentially toxic household products
5. Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Consecos Financial Flexibility and Potentially Disadvantage Other Shareholders
6. UNC study firms up promise of potential new cervical cancer screening tool
7. A potential route for human tumor gene therapy
8. High Growth Potential for Carotid Stent and Thoracic Aortic Stent Graft Markets
9. Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome
10. Estimated 3.2 million Burmese potentially affected by cyclone
11. Most Baby Boomers are Financially Unprepared for a Potential Disability
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech ... . Gary has spent a significant amount of time in Sweden since joining ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology: